SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-122503
Filing Date
2020-11-06
Accepted
2020-11-06 16:11:28
Documents
47
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20200930x10q.htm   iXBRL 10-Q 1315626
2 EXHIBIT 10.1 tmb-20200930xex10d1.htm EX-10.1 40159
3 EXHIBIT 10.2 tmb-20200930xex10d2.htm EX-10.2 421252
4 EXHIBIT 31.1 tmb-20200930xex31d1.htm EX-31.1 11677
5 EXHIBIT 31.2 tmb-20200930xex31d2.htm EX-31.2 10278
6 EXHIBIT 32.1 tmb-20200930xex32d1.htm EX-32.1 5705
7 EXHIBIT 32.2 tmb-20200930xex32d2.htm EX-32.2 5626
  Complete submission text file 0001104659-20-122503.txt   4801495

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA tmb-20200930.xsd EX-101.SCH 32930
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20200930_cal.xml EX-101.CAL 21548
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20200930_def.xml EX-101.DEF 139373
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20200930_lab.xml EX-101.LAB 236405
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20200930_pre.xml EX-101.PRE 218756
13 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20200930x10q_htm.xml XML 603761
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 212-554-4366
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38128 | Film No.: 201294528
SIC: 2834 Pharmaceutical Preparations